Pfizer’s Hospira Wins Legal Fees in Ruling by Biden Circuit Pick

Feb. 4, 2022, 1:27 AM UTC

Belcher Pharmaceuticals LLC must reimburse Pfizer Inc.’s Hospira “for every dollar that Hospira reasonably expended” on its lawyers during a patent-infringement dispute over epinephrine injections, based on inequitable conduct that Judge Leonard Stark called “truly exceptional in every way.”

The finding “certainly makes this case stand out from all the other cases I have seen,” Stark wrote in an order Thursday in the U.S. District Court for the District of Delaware. Stark has been nominated by President Joe Biden for the U.S. Court of Appeals for the Federal Circuit, and earlier in the day, he moved a step closer to ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.